Related Experiment Videos
Urologic applications of botulinum toxin therapy for voiding dysfunction
Raymond Rackley1, Joseph Abdelmalak
1Section of Voiding Dysfunction and Female Urology, Glickman Urological Institute, Cleveland Clinic Foundation, A100, 9500 Euclid Avenue, Cleveland, OH 44195, USA. RackleR@ccf.org.
Abstract:
Botulinum toxin is primarily a presynaptic neuromuscular blocking agent inducing selective and reversible muscle weakness up to several months when injected intramuscularly in small quantities. The clinical use of botulinum toxin type-A has gained widespread acceptance and application for numerous adult and pediatric spasticity syndromes. This has led to the urologic adoption of this minimally invasive therapy for the treatment of idiopathic and neurogenic detrusor overactivity, interstitial cystitis, detrusor-sphincter dyssynergia, urinary retention, and prostatic conditions. Outlined below is an overview of the clinical adoption of this therapy for the treatment of various dysfunctions of the lower urinary tract.
Related Concept Videos
Imaging Studies VI: Voiding Cystourethrography and Cystography
Urinary Tract Calculi III: Medical Management
Urodynamic Studies: Uroflowmetry
Anatomy of the Genitourinary System II: Bladder and Urethra
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations